AI Terminal
Assura PLC
Declaration of Voting Results & Voting Rights Announcements • Jul 30, 2021
4924_rns_2021-07-30_11ff6c2e-0492-449d-98db-3957bf5ed7eb.html
Declaration of Voting Results & Voting Rights Announcements
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 9704G
Assura PLC
30 July 2021
30 July 2021
Assura plc
Total Voting Rights
In conformity with the FCA's Disclosure Guidance and Transparency Rules DTR 5.6.1 we hereby notify that the company's issued share capital consists of:
Issued shares and voting rights
2,676,915,938 ordinary shares of 10 pence each ("Shares")
The above figure of 2,676,915,938 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, shares of Assura plc under the FCA's Disclosure and Transparency Rules. No shares are held in treasury.
- Ends -
For more information, please contact:
| Assura plc David Purcell, Head of Investor Relations |
Tel: 01925 420680 Email: [email protected] |
| Finsbury Gordon Simpson James Thompson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2021, Assura's property portfolio was valued at £2,453 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVREASXNAASFEFA